Synthesis and evaluation of 11β-(4-substituted phenyl) estradiol analogs: transition from estrogen receptor agonists to antagonists.
Synthesis and evaluation of 11β-(4-substituted phenyl) estradiol analogs: transition from estrogen receptor agonists to antagonists.
复制标题
DOI：
10.1016/j.bmc.2012.04.041
复制
发表时间：
2012-06-15
影响因子：
3.5
通讯作者：
Hochberg, Richard B.
中科院分区：
文献类型：
--
作者：
Hanson, Robert N.;Hua, Edward;Hendricks, J. Adam;Labaree, David;Hochberg, Richard B.
As part of our program to develop estrogen receptor (ER) targeted imaging and therapeutic agents we chose to evaluate 11β-substituted estradiol analogs as a representative scaffold. Previous synthetic studies provided an entry into this class of compounds and other work indicated that 11β-(substituted aryl) estradiol analogs were potent antagonists of the ER. Little information existed about the specific structural features involved in the transition from agonism to antagonism for the 11β-aryl estradiol analogs or their potential as scaffolds for drug conjugation. We prepared and characterized a series of 11β-(4-Substituted phenyl) estradiol analogs using modifications of existing synthetic methods. The new compounds, as well as standard steroidal agonists and antagonists, were evaluated as competitive ligands for the ERβ-LBD. Functional assays used the induction of alkaline phosphatase in Ishikawa cells to determine potency of the compounds as ER agonists or antagonists. The synthetic strategy successfully generated a series of compounds in which the 4-substituent was sequentially modified from hydroxyl to methoxy to azidoethoxy/N,N-dimethylaminoethoxy and eventually to a prototypical 1,4-naphthoquinone-containing moiety. The new compounds all retained high relative binding affinity (RBA) for the ERα-LBD, ranging from 13–83% that of estradiol. No subtype selectivity was observed. More importantly, the transition from agonist to antagonist activity occurs at the 4-methoxy stage where the compound is a mixed antagonist. More notably, antagonism appeared to be more dependent upon the size of the 11β-substituent than upon the nature of the terminal group We have developed a synthetic strategy that provides facile access to potent 11β-(4-substituted phenyl) estradiol analogs. The resultant compounds retain high affinity for the ERα-LBD and, more importantly, demonstrate potent antagonist activity in cells. Large functionalities distal to the 11β-phenyl ring had little additional effect on either affinity or efficacy, suggesting the incorporation of diverse imaging or biologically active groups can be attached without significantly compromising the ER-binding capacity. Future studies are in progress to exploit the 11β-aryl estradiol analogs as potential drug delivery systems and imaging agents.
登录
查看更多内容
影响因子：
3.8
作者：
Fan, Meiyun;Rickert, Emily L.;Weatherman, Ross V.
通讯作者：
Weatherman, Ross V.
影响因子：
3.6
作者：
Agouridas, V;Blazejewski, JC;Popkin, ME
通讯作者：
Popkin, ME
影响因子：
64.8
作者：
GREEN, S;WALTER, P;CHAMBON, P
通讯作者：
CHAMBON, P
影响因子：
56.9
作者：
EVANS, RM
通讯作者：
EVANS, RM
DOI：
10.1016/0960-0760(92)90392-v
发表时间：
1992-03-01
影响因子：
4.1
作者：
CLAUSSNER, A;NEDELEC, L;VANDEVELDE, P
通讯作者：
VANDEVELDE, P